| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |